Your browser doesn't support javascript.
loading
Study of active ingredients of Chinese medicine interfering with molecular signaling pathway of liver fibrosis / 中国药理学通报
Chinese Pharmacological Bulletin ; (12): 1638-1641, 2017.
Article in Zh | WPRIM | ID: wpr-667925
Responsible library: WPRO
ABSTRACT
The occurrence and progression of hepatic fibrosis are regulated by multicytokines and multiple molecular signal trans-duction pathways in cells. Currently,the molecular signaling pathway is the target for drugs to treat diseases. The study of the active ingredients of Chinese medicine to interfere with the sig-naling pathways of liver fibrosis is a hot topic. In the past ten years,it has been reported that hydroxysafflor yellow A,total flavonoids from litchi seed,ursolic acid,curcumin can interfere the signaling pathway of p38MAPK,TGF-β/ Smad,Wnt,Ras/ERK and Hedgehog liver fibrosis. The research on the active in-gredients of Chinese traditional medicine,which is targeted at signaling pathways,is expected to open new areas for Chinese and western medicine in the treatment of liver fibrosis.
Key words
Full text: 1 Database: WPRIM Language: Zh Journal: Chinese Pharmacological Bulletin Year: 2017 Document type: Article
Full text: 1 Database: WPRIM Language: Zh Journal: Chinese Pharmacological Bulletin Year: 2017 Document type: Article